Publication: 4018

Quality-of-life and symptom severity in the PALLAS randomized trial of palbociclib with adjuvant endocrine therapy in early breast cancer (AFT-05, ABCSG-42, BIG-14-03, PrE0109).

Citation:: ESMO Open vol 10 (6) 105120

Year:: 2025
Type:: Manuscript
Funding:: AFT
Endpoint:: Secondary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: pub

Note:

Methodological:: No
Biospecimen:: No
SDC:: No
Book Volume:: 15

Parents:: 3638
Children:: None

Program:: OGC
Primary Committee:: Breast
Sec. Committees:

Pharmas:: Pfizer
Grants:: ABCSG, ECOG-ACRIN, NSABP Foundation, GBG, BIG

Corr. Author:
Authors:: M J Naughton D M Zahrieh M Gnant N Zdenkowski J Lemieux J J Mao V Bjelic-Radisic E Shinn M Balic C Thomssen J L Meisel G M Ruiz S Loibl C Isaacs D Cameron F M Henao-Carrasco M P Goetz C F Singer G Werutsky H S Rugo M Vetter L-M Tseng K Miller F Fitzal J M Gil Gil H Park B Linderholm E Bajetta Z Dayao A Prat K Ehrhardt O Metzger A Arahmani E H Law A H Partridge L A Carey A Zoroufy A C Dueck P O'Brien D Hlauschek A DeMichele E L Mayer

Networks:: AL068, BHCRN, CA043, CAPITAL, LAPS-MA036, LAPS-MN026, LAPS-NC007, LAPS-NY016, LAPS-PA015, NC002, NEWMEXICO, VT004

Study: AFT-05
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 3

Keywords: